PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

about

Inhibition of angiogenesis as a new therapeutic target in the treatment of lepromatous leprosy.

P2860

Q40699468-B29D8F3B-5620-4D4B-B09C-B9CD032D9475

P2860

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

Item

http://www.wikidata.org/entity/Q36764870

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

@ast

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

@en

type

Item

label

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

@ast

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

@en

prefLabel

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

@ast

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

@en

P1476

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

@en

P2093

Andrius Kazlauskas

http://www.w3.org/2001/XMLSchema#string

Eunok Im

http://www.w3.org/2001/XMLSchema#string

P2860

The identification and characterization of two phosphatidylinositol-4,5-bisphosphate 4-phosphatases.

The autosomal recessive hypercholesterolemia (ARH) protein interfaces directly with the clathrin-coat machinery

The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase

Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor

Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology

Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin

The 2.7 A crystal structure of the activated FERM domain of moesin: an analysis of structural changes on activation

Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes

The phosphoinositide 3-kinase pathway

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

P304

443-451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.11.4.443

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17373875

http://www.w3.org/2001/XMLSchema#string

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

about

P2860

P2860

PtdIns-4,5-P2 as a potential therapeutic target for pathologic angiogenesis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698